DaVita to pay $450 mln in Medicare fraud lawsuit over wasted drugs

May 4 (Reuters) - DaVita HealthCare Partners Inc, one of the largest U.S. kidney dialysis providers, said it agreed to pay $450 million to settle a whistleblower lawsuit accusing it of deliberately wasting medicines in order to receive higher Medicare payments.